Діабет і природні та техногенні катастрофи: профілактика, підготовка, реагування та відновлення

Ендрю Дж. М. Боултон

Кафедра діабету, ендокринології та гастроентерології, Школа медичних наук, Манчестерський університет, Манчестер, Великобританія

Алісія Дженкінс

Інститут серця та діабету Бейкера, Мельбурн, Вікторія, Австралія

Мерхавіт А. Abera

Університетський коледж наук про здоров’я Мекелле, Мекелле, Ефіопія

Борис Маньковський

Кафедра терапії, вік-асоційованих захворювань
та діабетології, Національний університет охорони здоров’я України ім. П. Л. Шупика, Київ, Україна

Соломон Тесфайє

Відділ дослідження діабету, Шеффілдський навчальний госпіталь NHS Foundation Trust, Шеффілд, Великобританія

DOI :

Резюме

Поширеність діабету у світі та частота природних і техногенних катастроф зростають. З усіх хронічних захворювань наслідки раптового припинення постачання медикаментів є найбільш серйозними для людей з діабетом, оскільки люди, які живуть з цукровим діабетом 1-го типу, ризикують померти протягом декількох днів без інсуліну. У цьому огляді розглядається як підготуватися до раптового скорочення поставок медичних препаратів для людей з діабетом та як на нього реагувати. Описано нещодавній досвід пандемії COVID-19 в Індії, війни в Україні та війни/блокади в регіоні Тиграй в Ефіопії, а також обговорено важливість профілактики, готовності, реагування та відновлення. Сподіваємося, що уроки цих та інших катастроф, а також поточна адвокаційна діяльність та інші заходи допоможуть зменшити ризики значної захворюваності та смертності серед людей з діабетом у постраждалих від катастроф регіонах світу.

Ключові слова: пандемія COVID-19, діабет, керівництво, техногенні катастрофи, природні катастрофи.

 

Література:
  1. Government of Western Australia Department of Health (2019) Introduction to disaster management. Available from: https://www.health.wa.gov.au/~/media/Files/Corporate/ general%20documents/Disaster%20Managment/PDF/Introduction-to-Disaster-Management.pdf. Accessed: 15 Feb 2025
  2. IDF (2021) IDF diabetes atlas, 10th edn. IDF, Brussels, Belgium. Available from: https://www.diabetesatlas.org. Accessed: 28 Jan 2025
  3. Brennan F, Williams P, Armstrong K et al (2022) A human rights-based approach to improve access to insulin and other aspects of diabetes care. Diabetes Res Clin Pract 183:109153. https://doi.org/10.1016/j.diabres.2021.109153
  4. Jenkins AJ, Ogle GD, Scibilia R, Schwarz P, Brennan FP (2024) People who need insulin are particularly vulnerable in disasters and conflicts. BMJ 385:q1109. https://doi. org/10.1136/bmj.q1109
  5. Tokumaru O, Fujita M, Nagai S, Minamikawa Y, Kumatani J (2022) Medical problems and concerns with temporary evacuation shelters after great earthquake disasters in Japan: a systematic review. Disaster Med Public Health Prep 16(4):1645–1652. https://doi.org/10.1017/dmp.2021.99
  6. Damiri B, Abualsoud MS, Samara AM, Salameh SK (2018) Metabolic syndrome among overweight and obese adults in Palestinian refugee camps. Diabetol Metab Syndr 10:34. https://doi.org/10.1186/s13098-018-0337-2
  7. Shahin Y, Kapur A, Seita A (2015) Diabetes care in refugee camps: the experience of UNRWA. Diabetes Res Clin Pract 108(1):1–6. https://doi.org/10.1016/j.diabres.2015.01.035
  8. Rimawi A, Shah A, Louis H et al (2022) Community health worker program outcomes for diabetes and hypertension control in west bank refugee camps: a retrospective matched cohort study. Glob Health Sci Pract 10(5):e2200168. https:// doi.org/10.9745/GHSP-D-22-00168
  9. Ritchie H, Rosado P, Roser M (2024) Natural disasters. Available from: https://ourworldindata.org/natural-disasters. Accessed: 4 Oct 2024
  10. Kehlenbrink S, Smith J, Ansbro É et al (2019) The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries. Lancet Diabetes Endocrinol 7(8):638–647. https://doi.org/10.1016/S2213- 8587(19)30082-8
  11. Samei B, Babaie J, Tabrizi JS et al (2024) Exploring hospitals’ functional preparedness effective factors in response to disasters: a qualitative study in a lower middle-income country. BMC Health Serv Res 24(1):197. https://doi.org/10.1186/ s12913-024-10630-y
  12. Kyung DY, Hyo Jin K, Yunmi K et al (2019) Disaster preparedness for earthquakes in haemodialysis units in Gyeongju and Pohang, South Korea. Kidney Res Clin Pract 38:15–24. https://doi.org/10.23876/j.krcp.18.0058
  13. Jenkins A, Kadowaki T, Lee M-K on behalf of the IDF WPR (2022) Diabetes care and disasters: IDF Western Pacific Region, 2nd edn. Available from: https://idf.org/news/new- edition-of-diabetes-care-and-disasters-idf-western-pacific-region-manual/. Accessed: 28 Jan 2025
  14. Jenkins A, Lee MK, Kadowaki T, IDF-WPR (2023) Comprehensive IDF-WPR diabetes and disasters manual, 2nd edition available. Diabetes Res Clin Pract 195:110209. https://doi. org/10.1016/j.diabres.2022.110209
  15. Satoh J, Yokono K, Ando R, Asakura T et al (2019) Diabetes care providers’ manual for disaster diabetes care. J Diabetes Investig 10(4):1118–1142. https://doi.org/10.1111/jdi.13053
  16. Allweiss P (2019) Diabetes and disasters: recent studies and resources for preparedness. Curr Diab Rep 19(11):131. https:// doi.org/10.1007/s11892-019-1258-7
  17. Holman N, Knighton P, Kar P et al (2020) Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 8(10):823–833
  18. Hopkins D, Rubino F (2022) The effect of COVID-19 on routine diabetes care and mortality in people with diabetes. Lancet Diabetes Endocrinol 10(8):550–551. https://doi. org/10.1016/S2213-8587(22)00162-0
  19. Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 8(9):782–792. https://doi.org/10.1016/ S2213-8587(20)30238-2
  20. Hartmann-Boyce J, Highton P, Rees K et al (2024) The impact of the COVID-19 pandemic and associated disruptions in health-care provision on clinical outcomes in people with diabetes: a systematic review. Lancet Diabetes Endocrinol 12(2):132– 148. https://doi.org/10.1016/S2213-8587(23)00351-0
  21. Barron E, Bakhai C, Kar P et al (2020) Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol 8(10):813–822
  22. Xie Y, Al-Aly Z (2022) Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol 10(5):311–321. https://doi.org/10.1016/S2213- 8587(22)00044-4
  23. Rahmati M, Keshvari M, Mirnasuri S et al (2022) The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: a systematic review and meta-analysis. J Med Virol 94(11):5112– 5127. https://doi.org/10.1002/jmv.27996
  24. Birkebaek NH, Kamrath C, Grimsmann JM et al (2022) Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries. Lancet Diabetes Endocrinol 10(11):786–794. https://doi.org/10.1016/S2213- 8587(22)00246-7
  25. Bornstein SR, Rubino F, Khunti K et al (2020) Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 8(6):546– 550. https://doi.org/10.1016/S2213-8587(20)30152-2
  26. Steenblock C, Schwarz PEH, Ludwig B et al (2021) COV- ID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol 9(11):786–798. https:// doi.org/10.1016/S2213-8587(21)00244-8
  27. Khunti K, Aroda VR, Aschner P et al (2022) The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. Lancet Diabetes Endocrinol 10(12):890– 900. https://doi.org/10.1016/S2213-8587(22)00278-9
  28. UN Department of Economic and Social Affairs (2023) UN DESA Policy Brief No. 153: India overtakes China as the world’s most populous country. Available from: https://www. un.org/development/desa/dpad/publication/un-desa-policy-brief-no-153-india-overtakes-china-as-the-worlds-most- populous-country/. Accessed: 6 Feb 2024
  29. Anjana RM, Unnikrishnan R, Deepa M et al (2023) Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-IN- DIAB-17). Lancet Diabet Endocrinol 11(7):474–489. https:// doi.org/10.1016/S2213-8587(23)00119-5
  30. Zimmermann LV, Salvatore M, Babu GR et al (2021) Estimating COVID-19-related mortality in India: an epidemiological challenge with insufficient data. Am J Public Health 111(S2):S59–S62. https://doi.org/10.2105/ AJPH.2021.306419
  31. Agarwal N, Harikar M, Shukla R, Bajpai A (2020) COVID-19 pandemic: a double trouble for Indian adolescents and young adults living with type 1 diabetes. Int J Diabetes Develop Countries 40(3):346–352. https://doi.org/10.1007/s13410-020-00869-6
  32. Priya G, Bajaj S, Grewal E, Maisnam I, Chandrasekharan S, Selvan C (2020) Challenges in women with diabetes during the COVID-19 pandemic. Eur Endocrinol 16(2):100– 108. https://doi.org/10.17925/EE.2020.16.2.100
  33. Ramachandran A, Snehalatha C, Yamuna A et al (2006) Stress and undetected hyperglycemia in southern Indian coastal population affected by tsunami. J Assoc Physicians India 54:109–112
  34. Mithal A, Jevalikar G, Sharma R et al (2021) High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes. Diabetes Metab Syndr 15(1):169–175. https://doi. org/10.1016/j.dsx.2020.12.029
  35. Shrestha DB, Budhathoki P, Raut S et al (2021) New-onset diabetes in COVID-19 and clinical outcomes: a systematic review and meta-analysis. World J Virol 10(5):275–287. https:// doi.org/10.5501/wjv.v10.i5.275
  36. Maheshwari A, Hasnani D, Bhattacharya M et al (2023) Assessment of determining factors for severity of NeoCOVIDiabetes in India: a pan India multicentric retrospective study. Diabetes Metab Syndr 17(1):102692. https://doi. org/10.1016/j.dsx.2022.102692
  37. Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 15(4):102146. https://doi. org/10.1016/j.dsx.2021.05.019
  38. Anjana RM, Pradeepa R, Deepa M et al (2020) Accept- ability and utilization of newer technologies and effects on glycemic control in type 2 diabetes: lessons learned from lockdown. Diabetes Technol Ther 22(7):527–534. https:// doi.org/10.1089/dia.2020.0240
  39. Hwang Y, Khasag A, Jia W et al (2020) Diabetes and COVID-19: IDF perspective in the Western Pacific Region. Diab Res Clin Pract 166:108278. https://doi.org/10.1016/j. diabres.2020.108278
  40. Awuah WA, Mehta A, Kalmanovich J et al (2022) Inside the Ukraine war: health and humanity. Postgrad Med J 98(1160):408–410. https://doi.org/10.1136/postgrad- medj-2022-141801
  41. Khanyk N, Hromovyk B, Levytska O, Agh T, Wettermark B, Kardas P (2022) The impact of the war on maintenance of long-term therapies in Ukraine. Front Pharmacol 13:1024046. https://doi.org/10.3389/fphar.2022.1024046
  42. Haque U, Naeem A, Wang S et al (2022) The human toll and humanitarian crisis of the Russia-Ukraine war: the first 162 days. BMJ Global Health 7:e009550. https://doi.org/10.1136/ bmjgh-2022-009550
  43. Alessi J, Yankiv M (2022) War in Ukraine and barriers to diabetes care. Lancet 399(10334):1465–1466. https://doi. org/10.1016/S0140-6736(22)00480-9
  44. Maystruk G, Perone SA, Anufriyeva V et al (2022) Caring for people with diabetes and non-communicable diseases in Ukraine: a humanitarian emergency. Lancet Diabetes Endocrinol 10(5):308. https://doi.org/10.1016/S2213-8587(22)00105-X
  45. Neuman V, Vavra D, Drnkova L et al (2024) Introduction of continuous glucose monitoring (CGM) is a key factor in decreasing HbA1c in war refugee children with type 1 diabetes. Diabetes Res Clin Pract 208:111118. https://doi. org/10.1016/j.diabres.2024.111118
  46. Auzanneau M, Reinauer C, Ziegler J et al (2024) Diabetes care and outcomes of pediatric refugees and migrants from Ukraine and Syria/Afghanistan with type 1 diabetes in German-speaking countries. Front Endocrinol (Lausanne) 15:1403684. https://doi.org/10.3389/fendo.2024.1403684
  47. Tsagkaris C, Shkodina A, Matiashova L (2022) The war in Ukraine and diabetic foot care: challenges, recommendations. Diabetes Metab Syndr 16(10):102618. https://doi. org/10.1016/j.dsx.2022.102618
  48. Gebrehiwet TG, Abebe HT, Woldemichael A et al (2023) War and health care services utilization for chronic diseases in rural and Semiurban areas of Tigray, Ethiopia. JAMA Netw Open 6(8):e2331745. https://doi.org/10.1001/jama- networkopen.2023.31745
  49. Tigray War Project (2023) Call for Input to in- form the High Commissioner’s report to the Human Rights Council on the impact of casualty recording. Submission by the Tigray War Project (Ghent University) and Every Casualty Counts. 20 February 2023. Available from: https://view.officeapps.live.com/ op/view.aspx?src=https%3A%2F%2Fwww.ohchr.org%2Fsites%2Fdefault%2Ffiles%2Fdocuments%2Fissues- %2Fcasualtyrecording%2Fcfis%2Fhrc-res-50-11%2Fsu bm-casualty-recording-academia-ghent-university-51. docx&wdOrigin=BROWSELINK. Accessed: 6 Feb 2025
  50. Médecins Sans Frontières/Doctors Without Borders (2023) Ethiopia Tigray crisis. Available from: https://www.doc- torswithoutborders.ca/ethiopia-tigray-crisis/. Accessed: 6 Feb 2025
  51. Gufue ZH, Haftu HK, Alemayehu Y et al (2024) Damage to the public health system caused by war-related looting or vandalism in the Tigray region of Northern Ethiopia. Front Public Health 12:1271028. https://doi.org/10.3389/fpubh.2024.1271028
  52. IDF (2022) Call for urgent action to avert avoidable diabetes deaths in Tigray, Ethiopia. Available from: https://www.idf. org/news/249:call-for-urgent-action-to-avert-avoidable-diabetes-deaths-in-tigray.html. Accessed: 12 Aug 2024
  53. Clarfield AM, Gill G, Leuner CJ et al (2022) An appeal to world leaders: health care for Ethiopians in Tigray. Lancet 399(10323):433. https://doi.org/10.1016/S0140- 6736(22)00054-X
  54. Berhe E, Ross W, Teka H et al (2022) Dialysis service in the embattled Tigray Region of Ethiopia: a call to action. Int J Nephrol 2022:8141548. https://doi. org/10.1155/2022/8141548
  55. Legesse AY, Hadush Z, Teka H et al (2024) Lived experience of healthcare providers amidst war and siege: a phenomenological study of Ayder Comprehensive Specialized Hospital of Tigray, Northern Ethiopia. BMC Health Serv Res 24(1):292. https://doi.org/10.1186/s12913-024-10655-3
  56. Davies L (2022) Medics in Tigray plead with Ethiopia for insulin airlift as supplies run out. Available from: https:// www.theguardian.com/global-development/2022/jan/15/ medics-in-tigray-plead-with-ethiopia-for-insulin-airlift-as-supplies-run-out. Accessed: 12 Aug 2024
  57. Davies L (2022) ’Humanitarian crime’: fighting cuts off insulin supply in Tigray. Available from: https://www.the- guardian.com/global-development/2022/sep/23/fighting-cuts-off-insulin-supply-tigray-diabetic-ethiopia. Accessed: 18 Feb 2025
  58. Favara M, Hittmeyer A, Porter C et al (2022) Young people, mental health, and civil conflict: preliminary findings from Ethiopia’s Tigray region. Psychiatry Res Commun 2(1):100025
  59. Gebrekidan A, Haftu H, Hailu BY et al (2024) The effect of war and siege on children with diabetes admitted to Ayder comprehensive specialized hospital in Mekelle, Tigray, Ethiopia: a cross-sectional study. Sci Rep 14:25007. https:// doi.org/10.1038/s41598-024-76516-5
PDF (українська)

Опубліковано: 2025

Як цитувати:

Ендрю Дж. М. Боултон, Алісія Дженкінс, Брій Маккар, Борис Маньковський, Мерхавіт А. Абера, Соломон Тесфайє(2025). Діабет і природні та техногенні катастрофи: профілактика, підготовка, реагування та відновлення. Діабет Ожиріння Метаболічний синдром 3(14), 8-23.